创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Opportunities and Challenges of Small Molecule Targeted Therapeutic Drugs in the Era of Precision Medicine
ZHANG Ji
2023, 47(3): 161-163. DOI: 10.20053/j.issn1001-5094.2023.03.001
Abstract PDF
Advances in Research on Antitumor Drugs Based on Aldo-keto Reductase 1C3
LU Zhaoqiang, DUAN Jianxin, MENG Fanying, LI Anrong
2023, 47(3): 164-178. DOI: 10.20053/j.issn1001-5094.2023.03.002
Abstract PDF
The Role of Butyrylcholinesterase in Alzheimer's Disease and Design Strategies of Its Inhibitors
XING Shuaishuai, SUN Haopeng
2023, 47(3): 179-193. DOI: 10.20053/j.issn1001-5094.2023.03.003
Abstract PDF
Advances in Research on Small Molecule Inhibitors of Tropomyosin Receptor Kinase
YANG Xueqing, DAI Jinlian, WU Chenglong, LIU Zongliang
2023, 47(3): 194-206. DOI: 10.20053/j.issn1001-5094.2023.03.004
Abstract PDF
Advances in Research on Small Molecule Janus Kinase Inhibitors
LI Tong, LIU Ying, YE Lianbao
2023, 47(3): 207-216. DOI: 10.20053/j.issn1001-5094.2023.03.005
Abstract PDF
Research Progress of Berberine in Prophylactic Treatment of Diabetic Nephropathy
ZHANG Yachen, SUN Jianguo
2023, 47(3): 217-226. DOI: 10.20053/j.issn1001-5094.2023.03.006
Abstract PDF
Advances in Research on Immune Checkpoint TIGIT in Tumors
ZHU Zhu, ZHENG Heng
2023, 47(3): 227-234. DOI: 10.20053/j.issn1001-5094.2023.03.007
Abstract PDF
Outlook for 2023: Focus on Openness, Collaboration and Quality to Enhance the Value of Innovative Drugs
KONG Linghui, GE Qianwei, SHAO Liming
2023, 47(3): 235-240. DOI: 10.20053/j.issn1001-5094.2023.03.008
Abstract PDF